Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Biomarkers Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Biomarkers market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Biomarkers market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Biomarkers Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Biomarkers Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Biomarkers Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

F. Hoffmann-La Roche Ltd., Abbott, and Thermo Fisher Scientific, Inc. are Leading Market Players
The biomarkers market is a highly fragmented market. To strengthen their position, key market players are focusing on the introduction of novel biomarker tests, and entering in mergers and partnerships with other prominent companies with an aim to establish a strong brand presence. F. Hoffmann-La Roche Ltd., Abbott, and Thermo Fisher Scientific, Inc. dominated the biomarkers market share in 2018. Other players operating in the market are Bio-Rad Laboratories, Inc., Sino Biological Inc., BioVision Inc., Myriad RBM, R&D System, Axon Medchem, CENTOGENE N.V., and others.

List of key Companies Covered:

  
F. Hoffmann-La Roche Ltd.
  
Abbott
  
Thermo Fisher Scientific
  
Bio-Rad Laboratories, Inc.
  
CENTOGENE N.V.
  
Axon Medchem
  
Sino Biological Inc.,
  
R&D System
  
BioVision Inc.
  
Myriad RBM
  
Other players

REPORT COVERAGE

The biomarker market report provides detailed information regarding various insights of the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the biomarkers market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2019 to 2025 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources.

Report Scope & Segmentation

 

By Indication

  
Oncology
  
Cardiology
  
Neurology
  
Others

By End User

  
Pharmaceutical & Biotechnology Companies
  
Diagnostics & Research Laboratories
  
Hospitals & Specialty Clinics
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

INDUSTRY DEVELOPMENT:

May 2019: QIAGEN received FDA approval for therascreen RGQ PCR Kit. The therascreenPIK3CA Kit is the first companion diagnostic assay approved to identify breast cancer patients eligible for treatment with PIQRAY (alpelisib). PIQRAY (alpelisib), a newly approved therapy for breast cancer developed by Novartis AG.

May 2017: F. Hoffmann-La Roche Ltd., received the U.S. Food and Drug Administration (FDA) for biomarker assay for bladder cancer. This biomarker assay evaluates the status of patient PD-L1 by using both immune cell staining and tumor cell staining and scoring within the tumor.